Pneumococcal serotypes and virulence.

نویسنده

  • Daniel M Musher
چکیده

To the Editor—Pneumococcus is a venerable microorganism with an amazingly rich history. Those of us who study this organism should constantly examine our present findings in light of the wealth of previous literature. I am concerned when investigators draw conclusions from their own excellent but potentially limited data without referring to or noting discrepancies with that earlier body of knowledge. A case in point is the recent article by Sandgren et al. [1], on the virulence of pneumococci. The authors state that type 1 pneumococcal infection in humans is associated with a low mortality. Of the 4 references that they cite to support this statement [2–5], only 1 [4] actually provides data, and it bases this conclusion on a study of 12 isolates, the source of which was not stated. In contrast, Heffron [6] cites 11 studies from the preantibiotic era in which the overall mortality due to type 1 lobar pneumonia was 58% (range, 14%–82%) in 351 bacteremic cases and 15% (range, 3%– 23%) in 457 cases of nonbacteremic disease. The variability from one report to the next is interesting, because it shows the importance of citing broadly rather than narrowly, but one can hardly conclude that type 1 pneumococcus is not highly virulent in humans. Similarly, in the antibiotic era, Austrian and Gold [7] found a mortality of only 8% in bacteremic type 1 pneumonia, but Calder et al. [8] recorded 2 deaths in 7 cases, and Mufson et al. [9] noted 6 deaths in 21 cases. The characterization of these cases as being type 1 came about because this was the first strain that the Klemperers systematically studied; it could have been an accident but was not. In the recent epidemic of type 1 pneumococcal meningitis [10], the mortality was 44%. Nearly all the references cited in a recent article by Sandgren et al. [1] were from the preceding decade, most from the preceding 5 years, and discrepancies between their findings and those reported in the earlier literature were simply not addressed. I am not proposing that we weigh down our articles with early references, but I do think that it is important for investigators to maintain a close familiarity with older literature and to either cite similarities or try to explain or resolve discordant results.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Review: current and new generation pneumococcal vaccines.

Pneumococcal polysaccharide vaccines (PPVs) and conjugate vaccines (PCVs), of which PPV23 and PCV13 are the current front runners, have had a significant, beneficial impact on public health. With regard to PPV23, there has been some debate, however, about its protective efficacy against all-cause pneumonia, as opposed to invasive pneumococcal disease, in high-risk cases. PCVs, on the other hand...

متن کامل

Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence.

The recent discovery of a mobile genetic element encoding a pilus-like structure in Streptococcus pneumoniae and the demonstration of a role for the pilus in virulence in mice have led to the proposal of the use of the pilus as a candidate pneumococcal vaccine. We examined the frequency of occurrence of the pneumococcal pilus, as determined by the presence of the rrgC gene, and analyzed its ass...

متن کامل

Emerging, Non-PCV13 Serotypes 11A and 35B of Streptococcus pneumoniae Show High Potential for Biofilm Formation In Vitro

BACKGROUND Since the use of pneumococcal conjugate vaccines PCV7 and PCV13 in children became widespread, invasive pneumococcal disease (IPD) has dramatically decreased. Nevertheless, there has been a rise in incidence of Streptococcus pneumoniae non-vaccine serotypes (NVT) colonising the human nasopharynx. Nasopharyngeal colonisation, an essential step in the development of S. pneumoniae-induc...

متن کامل

Putatively novel serotypes and the potential for reduced vaccine effectiveness: capsular locus diversity revealed among 5405 pneumococcal genomes

The pneumococcus is a leading global pathogen and a key virulence factor possessed by the majority of pneumococci is an antigenic polysaccharide capsule ('serotype'), which is encoded by the capsular (cps) locus. Approximately 100 different serotypes are known, but the extent of sequence diversity within the cps loci of individual serotypes is not well understood. Investigating serotype-specifi...

متن کامل

Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen

The use of protein antigens able to protect against the majority of Streptococcus pneumoniae serotypes is envisaged as stand-alone and/or complement to the current capsular polysaccharide-based pneumococcal vaccines. Pneumolysin (Ply) is a key virulence factor that is highly conserved in amino acid sequence across pneumococcal serotypes, and therefore may be considered as a vaccine target. Howe...

متن کامل

Nonencapsulated Streptococcus pneumoniae as a cause of chronic adenoiditis

Streptococcus pneumoniae is an important human pathogen. To cause disease, it must first colonize the nasopharynx. The widespread use of pneumococcal-conjugate vaccines which target the capsular polysaccharide has led to decreased nasopharyngeal carriage of vaccine serotypes, but a concomitant increase in carriage of non-vaccine serotypes and nonencapsulated S. pneumoniae (NESp). Some NESp expr...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The Journal of infectious diseases

دوره 193 3  شماره 

صفحات  -

تاریخ انتشار 2006